Gerostate Alpha Cruises through Crowdfunding goal for antiaging drug platform

Gerostate reaches its crowdfunding target for anti-aging drug platform

Gerostate Alpha, a start-up incubated by Buck Institute, has reached its $300000 minimum funding goal with only two weeks left in its crowdfunding campaign. Longevitytech.fund, as the lead investor in the round, has also joined the company. This brings the total investment to the company up to $500,000.

Petr Sramek, managing partner of the investment firm, says, \”At Longevitytech.fund we invest in start ups that are focused on aging and will’move a needle’ materially.\” The team at Gerostate is well-positioned to achieve this in the next few years. We are excited to work with them on a long-term basis.

Longevity. Technology: Securing funding for early-stage biotech companies is difficult, especially those that target aging. Gerostate Alpha has been \”testing\” crowdfunding as a financing option and appears to have some success. To find out more, we spoke to the co-founders of Gerostate Alpha, Simon Melov and Mark Lucanic.

Source:

Gerostate passes crowdfunding goal for antiaging drug platform

Leave a Reply

Your email address will not be published. Required fields are marked *